Further studies are necessary to explore the detailed mechanism by which GM-CSF regulates iNOS and COX-2 expression in cervical cancer cells to support the potential applications of GM-CSF in clinical cervical cancer patients. This evidence concerns the gene NOS2 and cervical cancer.